SAFS can be a troublesome asthma. Patients are often adult male or females, with a mean age at diagnosis of ~50 years. Their pulmonary function measured by FEV1 or peak flow varies from 20-120% predicted, depending on how well their disease is controlled.
Don’t waste time! Our writers will create an original "BAFungal Diseases in Patients with Asthma" essay for youCreate order
Presentation: Many have significant nasal symptoms with runny nose, sneezing and hay fever- like symptoms. They do not produce plugs of sputum, like ABPA patients do, although CT scans may show some mucous in airways. ABPA is a hypersensitivity reaction rather than a true infection. – The pathogenesis of ABPA is not completely understood, but specific IgE-mediated type I hypersensitivity reactions, specific IgG-mediated type III hypersensitivity reactions, and abnormal T-lymphocyte cellular immune responses have all been implicated. – It most commonly occurs in patients with asthma or cystic fibrosis. Diagnosis – Patients with ABPA usually present with episodic wheezing, occasional productive cough Eosinophilia is common feature of SAFS. Most are completely dependent on high dose inhaled corticosteroids, with intermittent courses of oral steroids required for exacerbations, and some on continuous oral steroids. Chronic persistent asthma symptoms which are poorly controlled by multiple medications is a common feature for SAFS. Admission to hospital for asthma exacerbations is also common. The criteria for defining SAFS are
Evidence of sensitisation to one or more fungi, by skin prick test or RAST test Diagnosis and Diagnostic Criteria Criteria Used for the Diagnosis of ABPA Rosenberg-Patterson criteria A = Asthma R = Roentgenographic fleeting pulmonary opacities T = Skin test positive for Aspergillus (type I reaction, immediate cutaneous hyperreactivity) E = Eosinophilia P = Precipitating antibodies (IgG) in serum I = IgE in serum elevated (>1,000 IU/mL) C = Central bronchiectasis S = Serums A fumigatus-specific IgG and IgE (more than twice the value of pooled serum samples from patients with asthma who have Aspergillus hypersensitivity) Minor criteria
The disease is further classified as ABPA-S or ABPA-CB on the absence or presence of central bronchiectasis, respectively Minimal ABPA-CB (Central Bronchiectasis)
While some patients are sensitised to many fungi, the majority only react to one of two fungi. The commonest fungi that patients are sensitised to are A. fumigatus and C. albicans, with A. alternata, Trichopyton spp., Cladosporium herbarum, Penicillium chrysogenum and Botrytis cinerea. Treatment: Patients with SAFS are usually on multiple medications. Long-term inhaled and frequent courses of oral corticosteroids, usually control the patients’ worst symptoms, but have well known adverse events. These patients are usually already taking either short or long-acting beta-2 agonists, or leukotriene antagonists with some benefit. Antifungal therapy with itraconazole (200mg orally, twice daily) is beneficial in having a major effect on pulmonary and nasal symptoms. (Therapeutic drug monitoring is advised for itraconazole to optimize exposure to itraconazole, which may require switching between capsules and oral solution, and sometimes raising or lowering the dose). Fluconazole may be beneficial in those sensitised to Trichophyton spp. The required duration of antifungal therapy is uncertain.
We will send an essay sample to you in 2 Hours. If you need help faster you can always use our custom writing service.Get help with my paper